🧬 Why Does DNA Damage Cause Cancer in Some People but Not Others at the Same Rate?
Article summary: A new study revealed that inherited genetic factors play a crucial role in determining cancer risk and their impact on tumor development. The study explains how the interaction between inherited genes and mutations acquired during life can shape the evolutionary path of a tumor, which explains the difference in response to DNA damage among individuals exposed to the same environmental risks. These findings reinforce the importance of relying on analysis of an individual’s genetic background in prevention techniques, early detection, and cancer treatment.
🧠 The complexities behind some people developing cancer despite exposure to the same genetic damage
<pCancer begins as a result of the accumulation of changes in DNA molecules inside cells, scientifically known as mutations. These mutations lead to uncontrolled cell proliferation and disregard for the cell death signals that protect tissues from tumors.
Known environmental factors such as cigarette smoke or exposure to ultraviolet rays cause damage to DNA. However, despite groups of people being exposed to the same environmental factors, not all of them develop cancer. Most smokers, for example, do not develop lung cancer, while cancer appears in people who have never smoked. It has long been believed that heredity plays a role in this variation, but proving this directly has remained a challenge.
The many differences among humans in terms of environment and lifestyle make it difficult to attribute cancer risk to genes alone without other influences. From this standpoint, the research relied on animal models to provide a controlled experimental environment that regulates external variables.
🧪 An innovative way to understand the role of heredity in cancer development
An international team of scientists conducted an experiment on four different mouse strains, representing genetic diversity similar to that among humans from different regions. Each mouse was given a single dose of diethylnitrosamine (diethylnitrosamine – DEN), a carcinogenic substance that damages DNA and is found in cigarette smoke and some processed foods, under controlled environmental conditions to avoid any external effects.
Although all the mice were exposed to the same amount and effect of the damaging substance, the researchers observed a clear difference in tumor development among them. The findings were based on analyzing the genomes of nearly 600 tumors, in addition to monitoring rates of tumors that appear spontaneously without stimulation.
This experiment made it possible to investigate how the tumor develops starting from the mutation that caused it to appear, while linking differences in the evolutionary path to the genes that were inherited.
🧬 The effect of genetic background on tumor evolution pathways
The study found that tumors in the different mouse strains often activated the molecular pathway known as the MAPK pathway, a cell signaling system that controls growth and cell differentiation and is involved in many types of cancer.
Despite activation of the same main genomic pathway, each mouse strain had specific mutations that arose according to its genetic background. These mutations in turn affected other signaling systems that pave the way for cancer development.
It was also noted that some genetic backgrounds showed a clear tendency toward whole-genome duplication, a phenomenon in which the total set of chromosomes inside the cell doubles, an event associated with increased complexity in tumor evolution.
The lead researcher confirmed that cancer does not occur randomly only; rather, the path the tumor takes to reach its inevitable end depends to a large extent on the inherited genes of the individual.
🩺 The implications for screening strategies and personalized cancer treatment
The results indicate the need to reconsider early prevention methods and traditional cancer screening, so that they take into account genetic differences between individuals and population groups. This means that early screening approaches may need to better adapt to each person’s genetic background to increase detection accuracy and reduce dangerous cases.
Moreover, genetic background can affect patients’ response to treatments that attack the DNA of cancer cells. Therefore, developing treatment plans that target these differences can improve the effectiveness of medical interventions.
According to the researchers, these data open new horizons in the field of precision medicine, or what is known as precision treatment, which is designed according to the patient’s genetic and individual information.
🌱 What next? Challenges and points for future investigation
Despite the importance of these results, it must be emphasized that the study was conducted on animal models, which requires additional research on humans to understand the extent to which these results match human reality.
Providing strong evidence that the form of cancer development depends not only on environmental damage and acquired mutation but is also linked to the genetic background that hosts mutations could change our understanding of how cancer starts and lead to the development of more precise and effective ways to confront it.
This study is supported by funding from several prestigious research institutions, which confirms its importance in the scientific and medical arena.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
